Brief: Factor Bioscience And Eterna Therapeutics Announce Exclusive License And Collaboration Agreement To Accelerate Cell Therapy Development For Oncology, Autoimmune, And Rare Diseases

Ernexa Therapeutics

17/10/2024 13:28

Oct 17 (Reuters) - Eterna Therapeutics Inc  ERNA.O :
    * FACTOR BIOSCIENCE AND ETERNA THERAPEUTICS ANNOUNCE
EXCLUSIVE
LICENSE AND COLLABORATION AGREEMENT TO ACCELERATE CELL THERAPY
DEVELOPMENT FOR ONCOLOGY, AUTOIMMUNE, AND RARE DISEASES

Source text for Eikon:  ID:nPn1q95ppa 
Further company coverage:  ERNA.O 

 ((Reuters.Briefs@thomsonreuters.com;))